Navigation Links
Amgen and Onyx Pharmaceuticals Announce Upcoming Data Presentations at 55th American Society of Hematology Annual Meeting
Date:11/7/2013

cl-1 By The Combination Of Carfilzomib and TG02 In Multiple Myeloma

  • Dr. Katelyn Barnhart, Cancer Biology Graduate Program, Emory University
  • Sunday, December 8, 6:30 pm - 8:30 pm CT, Hall G
  • Poster presentation: Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II
  • Abstract # 3171

Combined Carfilzomib and Selective PI3Kδ Inhibition (TGR1202) Results in Enhanced Myeloma Cell Apoptosis

  • Dr. Claire Torre, Winship Cancer Institute, Emory University
  • Sunday, December 8, 6:30 pm - 8:30 pm CT, Hall G
  • Poster presentation: Myeloma: Therapy, excluding Transplantation: Poster II
  • Abstract # 3224

About PRISM

PRISM NTP (Proteasome Research and Integrative Science for Multiple Myeloma - Novel Therapies Program) is a global research collaboration between Onyx, investigators at myeloma centers of excellence and partner companies with novel therapies in development. PRISM NTP members come from five centers in the United States (Dana-Farber Cancer Institute/Partners, Emory, MD Anderson Cancer Center, Mayo Clinic Scottsdale and Mayo Clinic Rochester) and seven countries in Europe (France, Germany, Greece, Italy, Netherlands, Spain, United Kingdom). The program co-chairs are Dr. Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston and Dr. Jesus San Miguel, University of Navarra, Spain.  There are three working groups led by experts for each area of focus: molecular profiling, pre-cli
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
3. Amgen Announces 2012 First Quarter Dividend
4. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
5. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
6. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
7. Amgen to Acquire Micromet
8. Amgen to Present at the Leerink Swann Global Healthcare Conference
9. Amgen Announces 2012 Third Quarter Dividend
10. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
11. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer health ... EmblemHealth , the New York -based ... RedBrick Compass health assessment, combined with the RedBrick Journeys ... EmblemHealth is among the first health plans in the ...
(Date:1/15/2014)... January 15, 2014 Two champions of ... their sponsorship of an annual competition for middle and ... access to, innovative STEM study. The competition presents students ... Tests of Engineering Aptitude, Mathematics, and Sciences is ...
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... Washington, DC (PRWEB) January 14, 2014 ... session for Thursday, January 23, 2014 at 2pm EST ... Actionable Knowledge.” The topic focuses on how technology can ... mission critical decisions for government agencies. The online webinar ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
... SAN FRANCISCO, Oct. 12 In a study presented ... Chemotherapy (ICAAC), researchers used a mobile, automated UV device ... (VA) Medical Center in Ohio and analyzed its ability ... device, known as Tru-D, uses reflected UVC germicidal energy ...
... Oct. 12 ImaginAb, Inc. and BZL Biologics, LLC ... for the field of diagnostic imaging for PET and ... agreement with BZL as we believe that huJ591 will ... the diagnosis and management of prostate cancer. BZL,s technology ...
... in Europe,s healthcare industry were recognised at Frost ... held in London on 8th October 2009. 17 ... prestigious event. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ... including drug discovery technologies, healthcare and life sciences ...
Cached Biology Technology:Researchers Present 'a Novel, Automated, Efficient Environmental Disinfection Technology that Significantly Reduces C. difficile, VRE and MRSA Contamination' 2Researchers Present 'a Novel, Automated, Efficient Environmental Disinfection Technology that Significantly Reduces C. difficile, VRE and MRSA Contamination' 3ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA) 2Frost & Sullivan's 2009 Excellence in Healthcare Awards Banquet Honours Industry's Top Performers 2Frost & Sullivan's 2009 Excellence in Healthcare Awards Banquet Honours Industry's Top Performers 3
(Date:4/23/2014)... chronic inflammatory disorders among people of lower socioeconomic status ... to the microbes that thrive in rural environments, according ... in the journal Clinical & Experimental Immunology , ... less access to green spaces may be more apt ... system dysfunction. , When our immune systems are working ...
(Date:4/23/2014)... diagnosed with Huntington,s disease, most in their mid-thirties ... physical, and behavioral decline within two decades. "Mutant" ... the genetic disease, have been the primary focus ... according to new research from Prof. Gerardo Lederkremer ... Department of Cell Research and Immunology, in collaboration ...
(Date:4/23/2014)... NY. (Apr. 23, 2014) People who have had ... to restore neurological function. However, a study conducted in ... of Cell Transplantation , but is currently freely ... http://www.ingentaconnect.com/content/cog/ct/pre-prints/content-ct1168Chen , has found that when one group of ... (PBSCs) injected directly into the brain and a similar ...
Breaking Biology News(10 mins):Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3On the defensive 2On the defensive 3Autologous stem cell therapy improves motor function in chronic stroke victims 2
... Society by Joaquin Marro is a wide-ranging and accessible ... strategies and concepts that help us understand the boundaries ... and biology on the other. From cooperation ... addresses many of the topics belonging to the broad ...
... Even though multiple sclerosis is largely caused by genetic ... is lower than previously assumed. This is the conclusion ... scientific journal Brain . In the present ... risks for multiple sclerosis (MS) by using population registers ...
... nanotechnology we,ve gotten electronic skin, or e-skin, and electronic ... of electronic whiskers. Researchers with Berkeley Lab and the ... from composite films of carbon nanotubes and silver nanoparticles ... rats. These new e-whiskers respond to pressure as slight ...
Cached Biology News:Modest familial risks for multiple sclerosis 2E-whiskers 2
ERalpha (Ser 104/106)...
... Alkaline Phosphatase, Calf Intestinal (CIAP), catalyzes the ... and ribo- and deoxyribonucleoside triphosphates. This enzyme ... of linearized cloning vector DNA by removing ... also be used for the dephosphorylation of ...
Mouse CXCR3 Allophycocyanin MAb (Clone 220803)...
Homo sapiens palladin...
Biology Products: